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Abstract
Background: Work-related injuries result in considerable morbidity, as well as social and economic costs. Pain
associated with these injuries is a complex, contested topic, and narcotic analgesics (NA) remain important
treatment options. Factors contributing to NA utilization patterns are poorly understood. This qualitative study
sought to characterize the factors contributing to NA utilization amongst injured workers from the perspectives of
physicians and pharmacists.
Methods: The study employed concept mapping methodology, a structured process yielding a conceptual
framework of participants’ views on a particular topic. A visual display of the ideas/concepts generated is produced.
Eligible physicians and pharmacists (n = 22) serving injured workers in the province of Ontario (Canada) were
recruited via purposive sampling, and participated in concept mapping activities (consisting of brainstorming,
sorting, rating, and map exploration). Participants identified factors influencing NA utilization, and sorted these
factors into categories (clusters). Next, they rated the factors on two scales: ‘strength of influence on NA over-
utilization’ and ‘amenability to intervention’. During follow-up focus groups, participants refined the maps and
discussed the findings and their implications.
Results: 82 factors were sorted into 7 clusters: addiction risks, psychosocial issues, social/work environment factors,
systemic-third party factors, pharmacy-related factors, treatment problems, and physician factors. These clusters were
grouped into 2 overarching categories/regions on the map: patient-level factors, and healthcare/compensation
system-level factors. Participants rated NA over-utilization as most influenced by patient-level factors, while system-
level factors were rated as most amenable to intervention. One system-level cluster was rated highly on both
scales (treatment problems - e.g. poor continuity of care, poor interprofessional communication, lack of education/
support for physicians regarding pain management, unavailability of multidisciplinary team-based care, prolonged
wait times to see specialists).
Conclusions: Participants depicted factors driving NA utilization among injured workers as complex. Patient-level
factors were perceived as most influential on over-utilization, while system-level factors were considered most
amenable to intervention. This has implications for intervention design, suggesting that systemic/structural factors
should be taken into account in order to address this important health issue.
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It is estimated that over 100 million occupational inju-
ries occur each year worldwide [1]. Although estimates
vary considerably, most industrialized nations report
high rates of work-related injury [2-5]. The social and
economic costs associated with such injuries are sub-
stantial. In 2006, American employers spent $87.6 bil-
l i o no nw o r k e r s ’ compensation, although this does not
reflect personal and social costs [6]. In Europe, approxi-
mately 150 million work days are lost annually to work-
related injuries [7]. Work-related injuries are frequently
painful, with their management complicated by the sub-
jective nature of pain, uncertainty around the care of
persisting, ill-defined, or complex conditions, and diffi-
culties experienced by clinicians dealing with both
injured workers and employers [8]. While numerous
pharmacologic and non-pharmacologic treatments for
pain exist, opioid analgesics remain important options
for relieving pain [9]. The advent of new agents has
been accompanied by increased prescription of narcotic
analgesics (NA) in industrialized nations, raising con-
cerns about potential abuse [9-11]. These concerns have
been fueled by recent media attention, but empirical
studies have yielded mixed results - some indicating
increasing adverse outcomes and evidence of abuse,
others finding no change in the overall pattern [9-13].
Pain associated with work-related injury is a highly
complex and contested topic. Review of the return-to-
work (RTW) literature reveals little agreement regarding
how to define and operationalise outcomes, with pain
frequently dismissed as ‘subjective’ [14]. Pain manage-
ment in injured workers is likewise plagued by contro-
versy, with reports of increasing trends toward early NA
prescription for certain conditions (e.g. occupational low
back pain) despite guidelines recommending NA use
only in rare cases [15-17].
Recent interest in social scientific approaches to RTW
stems from growing recognition that RTW is not purely
a biophysical process, but rather the product of multiple
influences (e.g. psychological, social, structural/environ-
mental) [14,18-21] . Understanding the RTW process
from the perspectives of injured workers and health care
practitioners is important when interpreting observed
behaviours and outcomes. Prior studies eliciting work-
ers’ and employers’ perspectives on RTW have revealed
important barriers to the uptake of policies and prac-
tices [22,23], but the issue of NA utilization in the con-
text of work-related injury has not been addressed
specifically using qualitative research methods.
A few qualitative studies focused on NA utilization
specifically (outside RTW contexts) have been con-
ducted. Butler and colleagues used concept mapping
methodology to elicit patients’ and practitioners’
perspectives on drug-taking behaviours, but did not
explore factors external to the patient [24-26]. Few stu-
dies have sought the perspectives of practitioners
regarding NA prescription practices. A Norwegian study
of prescribers showed a general tendency to defer
responsibility to the previous physician, and to patient
autonomy [27]. However, these authors did not address
work-related injury.
Any attempt to improve quality of care in the RTW
arena (at the system, practitioner or worker level) must
first attempt to understand the factors driving current
practice patterns. There were two primary aims of this
study: 1) to understand the factors contributing to NA
utilization amongst injured workers from the perspec-
tives of physicians and pharmacists; and 2) to explore
physicians’ and pharmacists’ perspectives of how amen-
able these proposed factors are to intervention. A sec-
ondary aim was to compare perceptions between
physicians and pharmacists, as it was possible that the
two professions might view the issue differently.
Methods
Study design and participants
Qualitative methods are well-suited to studying complex
phenomena, including the contexts in which people live,
work and receive care [20,21]. Healthcare organization,
contextual factors, and the experiences and perspectives
of key stakeholders shaping practice behaviours - all
may be studied using qualitative methods. We con-
ducted a qualitative study using concept mapping (CM)
methodology. CM is “a structured process, focused on a
topic or construct of interest, entailing input from ...
participants, that produces an interpretable pictorial
view (concept map) of their ideas .... and how these are
interrelated” [28]. Although primarily qualitative in nat-
ure, CM has features of both qualitative and quantitative
approaches, entailing qualitative data collection coupled
with quantitative analytic techniques which are used to
create a visual display of how participants conceptualize
the topic. CM is comprised of three activities: 1) group-
based brainstorming, 2) individual web-based sorting
and rating, and 3) group exploration of the maps. Data
gathering activities are completed so that each partici-
pant’s viewpoint is represented while incorporating
group consensus (described below). This method was
proposed because it consider saw i d ea r r a yo ff a c t o r s
and organizes them into a coherent framework.
This was a collaborative project between St. Michael’s
Hospital and the Workplace Safety and Insurance Board
of Ontario (WSIB). Data collection occurred from
March to September 2008, at St. Michael’sH o s p i t a l
(Toronto, Ontario, Canada). The research protocol was
approved by the hospital’s Research Ethics Board.
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trative database of physicians and pharmacies serving
injured workers. An invitation letter was sent to poten-
tial participants informing them about the study. Inclu-
sion criteria were: physician or pharmacist licensed to
practice in Ontario; recent experience prescribing or dis-
pensing NA; registered as serving WSIB claimants; and
practicing within the greater Toronto area. Physician
and pharmacist RTW experts at the compensation
board (with relevant practice experience) were also
invited to participate. In keeping with qualitative metho-
dology, purposive sampling was conducted to promote
participation of those with varied levels of experience in
clinical practice.
Data collection and analytic procedures
While detailed descriptions of the CM method are
documented elsewhere [28-30], we outline each step
briefly below, including relevant analytic activities.
Brainstorming sessions (1.5 - 2 hours) were conducted
with three separate groups: community-based pharma-
cists, community-based physicians, and compensation
board expert clinicians (physicians and pharmacists).
The rationale for holding separate groups for commu-
nity-based physicians and pharmacists was to decrease
the possibility of social desirability bias, whereby one set
of professionals might not feel comfortable sharing their
views with another (potential power differential). There
were insufficient numbers of pharmacists among the
compensation board experts to hold a separate group
with these individuals. Participants were asked to com-
plete the following sentence: “A factor which influences
NA utilization amongst patients experiencing work-
related injuries/illnesses is ...” Participants were encour-
aged to generate as many statements as possible that
would complete this sentence. A definition of ‘NA’ was
provided to ensure consistency within and across groups
and read as follows: “Narcotic analgesics (NA) are pain
relievers that work on the central nervous system (CNS)
to alter the perception of pain. Examples are: codeine,
fentanyl, hydrocodone, hydromorphone, meperidine,
methadone, morphine, & oxycodone. For the purposes
of this study, we are interested in narcotic analgesics as
prescribed for the treatment of chronic non-malignant
pain in patients who have experienced work-related
injuries or illnesses.” Item lists from all groups were
merged (duplicates eliminated and like items consoli-
dated), to yield a master list capturing all unique ideas
generated.
Sorting and rating of items was then conducted online
individually using Concept Systems (CS) Global software
(version 4) [31]. Participants were first asked to sort the
i t e m si n t og r o u p st h a t“made sense to them” and to
label them accordingly to reflect the items within. Next,
participants rated each factor according to their percep-
tions of:
a) how strongly it influences NA over-utilization
(rated as 1 = not at all (does not influence NA over-
utilization) to 5 = very strongly influences NA over-
utilization)
b) how amenable it is to intervention (where 1 = not
at all amenable and 5 = extremely amenable)
Upon completion of sorting and rating, data were
exported into the CS Core system, which is necessary in
order to conduct multidimensional scaling and hierarch-
ical cluster analysis [30]. Information about the distance
of each item to all other items was produced to illus-
trate clusters of items, representing conceptual domains.
All participants’ data were used to produce a single
aggregate map representing the collective viewpoint of
participants.
The aggregate map was shared with participants in
follow-up focus groups for confirmation and further dis-
cussion and refinement [30]. Fifteen participants
returned for this activity, confirming the appropriate
number of clusters, the positioning of items within clus-
ters, and refining the cluster labels. A 7-cluster solution
was confirmed and consensus reached. Based on feed-
back from these focus groups, the final aggregate map
was produced, with a stress value of 0.27 (well within
the acceptable range reported in the CM literature, indi-
cating excellent goodness-of-fit for the resulting model)
[30]. Finally, pattern matches and go-zones were
employed to look at relative agreement on the ratings
between groups (e.g. between physicians and pharma-
cists, those with lower versus those with higher levels of
practice experience, and between compensation board
experts and community-based practitioners) [30].
Results
Pharmacists were contacted for participation via 22 local
pharmacies identified from the WSIB dispensing data-
base as high-volume dispensers of NA to injured work-
ers. Fourteen declined participation, most (n = 12)
citing staff shortages, long work hours and travel dis-
tance to attend the group sessions as the primary rea-
sons for refusal. Eight community-based pharmacists
took part in the study. Thirty-eight eligible local com-
munity-based physicians were identified and contacted
(first by letter then by phone). Of these, 4 could not be
reached because of incomplete/incorrect contact infor-
mation, 10 did not call back despite repeated attempts,
and 15 declined to participate outright. Nine commu-
nity-based physicians expressed interest and willingness
to participate in the study, but only 6 were ultimately
available to attend the group sessions. Compensation
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were identified from within the consultant staff at the
WSIB and invited to participate in the brainstorming
sessions. Eight practitioners participated. Compensation
board participants were also community-based
practitioners.
A total of 22 participants attended the brainstorming
groups (13 physicians, 9 pharmacists). Ten were men
and 12 were women, with a mean age of 46 years (range
= 29 - 64). Mean number of years practicing their desig-
nated profession was 18 (range = 2 - 40 years). Eight
compensation board expert clinicians (mean practice
experience = 14.9 years, range = 4 - 30 years), 6 com-
munity-based physicians (mean experience = 18.3 years,
range = 2 - 36 years) and 8 community-based pharma-
cists (mean experience = 21.3 years, range = 7 - 40
years) participated in the brainstorming groups. More
participants took part in brainstorming with 4 fewer of
the original 22 participants performing sorting and rat-
ing (n = 18; 10 physicians, 8 pharmacists), which is
common and acceptable practice in CM projects [30].
These 4 persons were unavailable during the scheduled
period for this activity.
Relevant factors and concept map
Additional File 1 presents the master list of 82 items
generated by participants (grouped by cluster label).
These factors ranged from those related to patients/
workers themselves (including psychosocial context),
medication, work environment, healthcare and compen-
sation systems, to prescriber and dispenser factors.
Participant sorting activities yielded point maps and
cluster maps. The final 7-cluster map is presented in
Figure 1. Items in each cluster are denoted by numbers
which correspond to the item numbers in the table in
Additional File 1. The numbers are not ordered or
ranked, but simply correspond to the item they denote.
Items that appear closer on the map are perceived by
participants to be more closely related to each other.
Figure 1 represents a unique conceptualization of factors
perceived to be influencing NA utilization amongst
injured workers. The clusters and their associated fac-
tors can be summarized as follows: (1) systemic-third
party factors (including relationship between workers
and compensation board, claims issues, lack of work-
place accommodations, etc.), (2) social/work environ-
ment factors (e.g. stigma of being on compensation, lack
of family and other supports, job description, unsuppor-
tive attitudes of employers, etc.);
(3) psychosocial issues (e.g. motivation to RTW, socio-
economic status, experience of disability, cultural norms
and expectations); (4) addiction risks (e.g. presence of
comorbidities, previous history of addiction, poor
patient-physician relationship, noncompliance); (5)
physician factors (e.g. clinician’s expectations around
pain management, physician’s attitude/belief in patient’s
pain, and pressures on physicians to see large volume of
patients in fee-for-service healthcare system); (6) treat-
ment problems (including lack of continuity of care,
long wait times to see specialists, clinician lack of aware-
ness of non-NA options, poor availability of multidisci-
plinary team-based care, poor physician education in
pain management); and (7) pharmacy-related factors (e.
g. the addictive nature of the NA initially prescribed,
use of long-acting rather than short-acting NAs, poor
availability of effective alternative medications, barriers
to pharmacists educating patients, availability of online
drug plans/prescription databases). Additional File 1
provides a detailed consideration of all 82 factors
grouped by cluster.
The reader is reminded that this conceptualization
incorporates the perspectives of physicians and pharma-
cists experienced in working with this population. Each
cluster represents a conceptual domain, with the 7 clus-
ter labels developed by the participants themselves,
using their own words and through a process of consen-
sus. The 7 categories generated can be seen as clustering
into two over-arching regions on the map, with the 3
clusters in the upper half comprising one region and the
bottom 4 clusters comprising another:
1) The upper region (Social/Work Environment Fac-
tors, Psychosocial Issues and Addiction Risks) is com-
posed of factors related to the injured worker and the
context in which they live, work and receive care.
2) The lower region (Systemic-Third Party Factors,
Pharmacy-Related Factors, Treatment Problems and
Physician Factors) deals with system-level factors
related to the healthcare and compensation systems.
Rating maps
Clusters with more ‘layers’ are more highly rated by par-
ticipants, while those with no layers (flat clusters) are
seen as less important (Figures 2 and 3).
Factors influencing NA over-utilization amongst injured
workers
Figure 2 demonstrates that several clusters were seen as
influencing NA over-utilization. The cluster ‘Addiction
Risks’ was rated most influential (4 layers), while the
clusters ‘Treatment Problems’ and ‘Psychosocial Issues’
were next most influential (3 layers each). By contrast,
‘Systemic-Third Party Factors’ and ‘Physician Factors’
were seen as having less influence on NA over-utiliza-
tion (0 layers each). Table 1 provides more detailed
information concerning individual items contributing to
the ratings among two highly-rated clusters (’Addiction
Risks’, ‘Treatment Problems’).
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Figure 1 Cluster Map. Items in each cluster are denoted by numbers which correspond to the item numbers in Additional file 1. The numbers
are not ordered or ranked, but simply correspond to the item they denote.
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Figure 2 Ratings: Strength of Influence on NA over-utilization.
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Page 5 of 13Factors amenable to intervention
Figure 3 is a cluster rating map depicting participants’
perspectives concerning the factors’ relative amenability
to intervention (to optimize NA utilization). Factors
within the cluster ‘Treatment Problems’ were seen as
most amenable to intervention (4 layers), while the clus-
ters ‘Physician Factors’ and ‘Pharmacy-Related Factors’
(3 layers each) were seen as next-most-amenable to
intervention. By contrast, the clusters ‘Addiction Risks’,
‘Psychosocial Issues’ and ‘Work/Social Environment
Factors’ were not seen as amenable to intervention by
participants. Table 2 provides more detailed information
concerning individual items contributing to the ratings
among the three most highly rated clusters (’Treatment
Problems’, ‘Physician Factors’ and ‘Pharmacy-related
Factors’).
Comparing the two rating maps
If we subdivide the maps into 2 over-arching regions
(upper comprised of 3 patient-related clusters, lower of
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Figure 3 Ratings: Amenability to Intervention.
Table 1 Factors (items) influencing cluster ratings for NA over-utilization
Cluster Influential items (factors) within cluster Item #
Addiction Risks
patient’s history of NA use 28
patient’s history of addiction 45
presence of comorbid conditions in patient (including psychological/mental) 40
patient’s request for NA 35
Treatment Problems
poor or absent protocols for weaning patients off NA 27
lack of education/support for physicians in pain management (i.e. lack of guidelines) 52
unavailability of multidisciplinary team-based care 44
inability to get non-pharmacological treatments (e.g. physiotherapy, acupuncture, massage therapy) 54
lack of continuity of care 36
lack of resources in assisting patients with NA addiction/withdrawal 21
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Page 6 of 134 system-level clusters) the rating distributions indicate
that participants perceived patient-related factors to be
driving NA over-utilization. However, the factors per-
ceived to be most amenable to intervention are system-
level factors (i.e. those operating external to injured
workers). Only one system-level cluster (’Treatment Pro-
blems’) was rated highly on both scales. Otherwise, there
was little overlap in terms of what was considered most
influential to NA over-utilization and relative amenabil-
ity to intervention.
Finally, we generated pattern matches and go-zones to
examine the extent to which physicians and pharmacists
agreed on cluster ratings [30]. Pattern matches yield
simple ‘ladder graphs’, with the two vertical axes repre-
senting the mean ratings for each cluster [26]. Figure 4
depicts relative inter-disciplinary agreement regarding
cluster ratings on amenability to intervention. Physician
ratings appear on the left and pharmacist ratings on the
right. Each horizontal line between the vertical axes
represents a cluster on the concept map. A correlation
value of 0.79 at the bottom of the graph indicates that
there is relatively high agreement between the disci-
plines [30]. The horizontal lines for ‘Treatment Pro-
blems’ at the top (highly rated by both disciplines) and
at the bottom for ‘Social/Work Environment Factors’
(rated low by both disciplines) indicate a high degree of
agreement on these particular clusters. The differences
evident in the middle of the graph likely reflect
differences based on experiences and role of each disci-
pline in managing pain in injured workers.
Go-zones are XY graphs of ratings divided into quad-
rants based on the mean for each variable [30]. Figure 5
depicts the relative agreement between physicians and
pharmacists regarding their ratings of each factor’s amen-
ability to intervention within the ‘Treatment Problems’
cluster specifically. This graph demonstrates a high
degree of agreement on the ratings between both groups
(r = 0.81) [30]. The upper left quadrant of the graph
includes items rated higher by pharmacists and lower by
physicians. Only one item sits in this quadrant (67, ‘insuf-
ficient treatment, leading to withdrawal pain, leading to
higher doses’). The right lower quadrant includes items
rated higher by physicians and lower by pharmacists.
Again, only one item sits in this quadrant (25, ‘pharma-
cist and physician lack of knowledge of non-NA
options’). Those items in the left lower quadrant indicate
items that were rated lower by both pharmacists and
physicians, while those in the upper right quadrant indi-
cate items that were rated highly by both disciplines -
again indicating a high degree of agreement on most
item ratings in this cluster. Appendix 1 provides a brief
description of additional comparisons conducted.
Discussion
This study represents an original contribution by produ-
cing a conceptual map of factors influencing NA
Table 2 Factors (items) influencing cluster ratings for amenability to intervention
Cluster Influential items (factors) within cluster Item
#
Treatment Problems
prolonged time to accurate diagnosis 31
lack of continuity of care 36
poor interprofessional communication 66
lack of education/support for physicians in pain management (i.e. lack of guidelines) 52
unavailability of multidisciplinary team-based care 44
inability to get non-pharmacological treatments (e.g. physiotherapy, acupuncture, massage therapy) 54
lack of resources in assisting patients with NA addiction/withdrawal 21
pharmacist and physician lack of knowledge of non-NA options 25
Physician Factors
clinician’s expectations around pain management (e.g. goal of ‘zero pain’) 38
(lack) of a contract between physicians and patients (narcotic contract) 76
Pharmacy-related
Factors
poor availability of effective alternative medications (including non-narcotic medications) 53
use of long-acting rather than short-acting NAs 59
availability of drug plan online, so pharmacist is aware of number of prescriptions, frequency of refills, available
substitutions
37
no upper limit of NA dosage 60
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Page 7 of 13utilization amongst injured workers, drawing specifically
on the perspectives of physicians and pharmacists. Parti-
cipants portrayed a complex and multifaceted phenom-
enon, depicting injured workers within their personal
and social contexts, and identifying numerous factors
operating at multiple levels. This is the first study to
characterize the topic in a comprehensive manner, and
to attempt to interrelate the contributing factors within
a coherent framework.
Surprisingly, participants saw system-level factors as
more amenable to intervention, despite their perceptions
that patient-level factors are most influential to NA
over-utilization in this population. Numerous quantita-
tive studies of NA usage have been conducted (some in
t h ec o n t e x to fR T W ) ,a n dt h em a j o r i t yf o c u so ni d e n t i -
fying individual factors/characteristics that put patients
a tr i s kf o ra b u s e( e . g .a g e ,p s ychiatric comorbities, his-
tory of substance abuse) [15-17,32,33]. Russell and col-
leagues (2005) conducted a qualitative study of family
practitioners related to managing RTW patients gener-
ally (not focused on NA) which revealed that physicians
viewed ‘external influences’ (compensation boards,
employers, etc.) with suspicion [8]. In contrast, our par-
ticipants indicated that they would welcome further gui-
dance in managing workers from a variety of sources
(including compensation boards). Interestingly, a large
scale quantitative study by Shaw and colleagues (2005)
looking at RTW reported that RTW and shorter
Figure 4 Pattern Match: Comparing Physician and Pharmacist Cluster Ratings - Amenability to Intervention.
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Page 8 of 13duration of disability were predicted by employment fac-
tors rather than individual patient history and physical
examination [34].
Participants identified only one cluster of system-level
factors (’Treatment Problems’) as both strongly influen-
cing NA overuse and highly amenable to intervention.
This suggests that addressing the factors within this
cluster is where interventions hold greatest promise of
impacting NA utilization. This was surprising because
to date, most interventional studies addressing NA over-
use have focused on individual behaviour change
(patient-level) [35-41]. Our clinician participants instead
indicated that there were changes at the system-delivery
level that could be implemented to improve NA utiliza-
tion amongst injured workers. This demonstrates the
importance of employing both rating maps to under-
stand the problem and its potential solutions. If we
relied solely on Figure 2 (perceived drivers of over-utili-
zation), we might erroneously conclude that interven-
tions should be targeted primarily at the level of
patient/worker behaviour change. Instead, participants
identified practice- and system-level factors as more
amenable to intervention. Participants rated one cluster
(’Treatment problems’) highly on both rating scales
(important influencers on overutilization and most
amenable to change), suggesting that this might be the
set of factors to which interventions should be targeted
to improve outcomes. Tables 1 and 2 indicate that five
factors specifically were ranked as particularly important
to NA overutilization as well as being amenable to inter-
vention. These were: ‘lack of education/support for phy-
sicians in pain management’ (52), ‘unavailability of
multidisciplinary team-based care’(44), ‘inability to get
non-pharmacologic treatments’ (54), ‘lack of continuity
of care’ (36), and ‘lack of resources in assisting patients
with NA addition/withdrawal’(21). This suggests that
optimizing collaboration between physicians, pharma-
cists, clinical specialists, compensation experts, and
injured workers may be most important to improving
worker well-being and reducing the associated costs of
time off work. That being said, the care of workers with
chronic pain is complex and multifaceted approaches
will be needed, with implementation of strategies target-
ing providers and treatment, coupled with an
Figure 5 Go-Zone: Comparing Physician and Pharmacist Item Ratings of ‘Treatment Problems’ Cluster - Amenability to Intervention.
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Page 9 of 13exploration of novel approaches to address patient-level
factors. Intervention studies would have to be conducted
to determine whether focusing on these factors trans-
lates into reductions in NA use.
Given that participants emphasized the lack of educa-
tion/support for physicians in managing pain in injured
workers, an intervention such as academic detailing
might be an appropriate initial step to improving prac-
tice [42]. Such approaches incorporate face-to-face
interactions with trusted expert clinicians, and are
thought to be more successful than traditional guideline
dissemination approaches to changing practice [43]. Par-
ticipants suggested a number of avenues for improving
interprofessional communication between physicians
and pharmacists (e.g. through an electronic prescription
monitoring system) [44], and an enhanced role for com-
pensation boards for communicating existing commu-
nity-based resources for accessing specialty services and
non-pharmacologic care.
While there was considerable agreement between phy-
sicians and pharmacists regarding the cluster ratings,
the minor differences identified on the pattern matches
and go-zones are intriguing. These may be largely
explained by the specific roles physicians and pharma-
cists play in the pain management of injured workers. In
the pattern match, pharmacists ranked ‘Addiction Risks’
as more amenable to intervention than physicians. It
may be that pharmacists are more aware than family
physicians regarding strategies for managing addiction
risks. Conversely, physicians ranked ‘Systemic-Third
Party Factors’ as more amenable to intervention than
pharmacists. This could be explained by the fact that
physicians have more interaction with compensation
boards (emphasized in the cluster ‘Systemic-Third Party
Factors’) than do pharmacists, and so are likely more
aware of opportunities for process redesign within that
cluster. Interestingly, physicians ranked ‘Pharmacy-
related Factors’ as more amenable to intervention than
‘Physician-related Factors’, while pharmacists were more
optimistic that ‘Physician-related Factors’ could be
improved than were physicians themselves.
W h i l eo u r si st h ef i r s ts t u d yt oa d d r e s st h i st o p i c
using CM, others have used CM to explore opioid utili-
sation generally. Butler and colleagues conducted a ser-
ies of CM studies (2004, 2006, 2007) as a preliminary
step in developing patient self-report measures of pre-
scription opioid abuse [24-26]. None of these studies
evaluated injured workers, and Butler focused exclu-
sively on patient-level drug-related behaviours. The pur-
pose of using CM in our study was different, as we
sought to catalogue a broad array of factors contributing
to current NA utilization patterns (specifically in injured
workers), and to organize them into a coherent frame-
work. The study’s results have confirmed that many
factors beyond the injured worker are perceived to influ-
ence NA utilization. The participants in our study chose
instead to emphasize the shortcomings of the healthcare
system.
Two additional qualitative studies (neither employing
CM nor focusing on work-related injury) have been
conducted concerning NA prescription, one eliciting
providers’ perspectives, the other patients’ [27,45]. Dyb-
ward and colleagues (1997) focused on NA prescription
behaviours amongst Norwegian family doctors [27].
Like our participants, Norwegian practitioners depicted
NA prescription as difficult work, but they emphasized
patient-related factors (age, concomitant disease, auton-
omy) and a tendency to defer to the previous doctor to
rationalize practice patterns [27]. Blake (2007) studied
patients’ perspectives of NA prescription for chronic
pain, describing how patients balanced pain relief
against concerns regarding side effects (and fear of
addiction) [45]. The stigma of being perceived as
addicted, the effects of pain on all aspects of their lives,
and their ambivalence towards taking NA indicate that
it is a complex process for patients as well [45]. The
qualitative literature on RTW indicates that patients
characterize the RTW journey as very complex and
multi-faceted [14,22,23], far more so than is usually
characterized by the clinicians interacting with them.
The way RTW is characterized in the literature from
practitioners’ and epidemiologists’ viewpoints is usually
overly simplistic [18], with assumptions that workers
simply are trying to return to their premorbid status.
But we know that for persons experiencing major illness
or injury, the journey back to work is shaped by many
factors (e.g. nature of illness/injury, the type of treat-
ment received, family structure and social supports,
gender, age and life stage, education and socioeconomic
status, the type of work engaged in (job demands), per-
sonal perspectives and societal discourses regarding dis-
ability, being on compensation, being unemployed, and
shifting notions of the meaning of work in their lives)
[14,23]. We also know that patients’ and practitioners
perspectives’ often differ, whether concerning care
received, health conditions treated, or expectations of
recovery. For example, Kapoor and colleagues (2006)
found that patient and physician expectations of RTW
following occupational low back pain differed consider-
ably [46]. A quantitative study by Mäntyselkä et al.
(2001) comparing patients’ and family physicians’ rat-
ings of patients’ pain found considerable discordance
between the groups, with physicians consistently rank-
ing intensity lower than patients. The discordance
became more pronounced as the severity of patients’
ratings increased [47]. Future investigations using con-
cept mapping methodology with injured workers is
warranted.
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This study has several limitations. First, we did not seek
injured workers’ perspectives, partly because of recent
Canadian privacy regulations, and partly from concerns
about not further stigmatizing this population. Instead,
an exploratory study focusing on prescribers’ and dis-
pensers’ views was seen as an appropriate first step to
understanding NA utilization patterns. Second, these
findings are based on practitioner perceptions. Neverthe-
less, perceptions inform behaviour and understanding,
and as such offer valuable insights. Like all qualitative
findings, ours are not meant to be generalisable at the
population level. Rather we have produced a conceptual
map highlighting linkages between factors from the per-
spectives of practitioners. While our participants prac-
tice in a particular jurisdiction (Ontario, Canada), the
findings should be of interest to practitioners in other
jurisdictions nationally and internationally. Concerns
identified here - regarding interprofessional communica-
tion, coordination of care, availability of clinical practice
guidelines, balancing pain relief against unwanted NA
side effects - have been alluded to by international
investigators [48-50].
Conclusions
In summary, our study puts the context surrounding
work-related injuries, NA utilization and clinician per-
spectives together, offering ac o n c e p t u a lf r a m e w o r kf o r
understanding factors contributing to this phenomenon.
N o to n l yh a v ew ei d e n t i f i e df a c t o r sp e r c e i v e dt oi n f l u -
ence NA over-utilization, but we have also identified
factors perceived to be amenable to intervention. Sur-
prisingly, while patient-related factors were seen as pri-
mary drivers of over-utilization, system-level factors
were seen as most amenable to intervention. As such,
these findings suggest areas for practice improvement.
Appendices
Appendix 1: Additional comparisons
While only comparisons between physicians and phar-
macists are reported here, we also compared compensa-
tion board experts and community-based practitioners,
as well as those with ≤ 10 years practice experience ver-
sus those with more than 10 years practice experience.
Between-group ratings for the clusters on the pattern
matches were highly correlated (r = 0.95) in both cases,
indicating that compensation experts and community
practitioners held very similar views, as did practitioners
with varying years of practice experience.
Additional material
Additional file 1: Statement (Factor) List. This table provides the full
list of all 82 factors (items) generated by participants. The table also links
each factor with its relevant cluster. (Please see ‘Additional files’ uploaded
with this article).
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